AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $43,000 | -87.2% | 786 | -81.7% | 0.00% | – |
| Q4 2020 | $335,000 | +256.4% | 4,293 | +234.3% | 0.00% | – |
| Q3 2020 | $94,000 | -47.8% | 1,284 | -41.7% | 0.00% | – |
| Q2 2020 | $180,000 | -45.3% | 2,202 | -30.8% | 0.00% | – |
| Q4 2019 | $329,000 | +631.1% | 3,180 | +44.1% | 0.00% | – |
| Q3 2019 | $45,000 | -13.5% | 2,207 | +8.6% | 0.00% | – |
| Q2 2019 | $52,000 | – | 2,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |